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The severity of seizures presenting to the emergency department ranges from benign to life threatening. There are also a wide
number of possible etiologies. Computed tomography (CT) emergency imaging may be required at presentation to elucidate a
possible cause and assess signs of intracranial trauma. This case describes a serious seizure episode in a young man while on
holiday. A CT brain showed a skull fracture as a consequence of seizure-related head trauma but unexpectedly there were image
findings consistent with encephalocraniocutaneous lipomatosis. The important radiological features of encephalocraniocutaneous
lipomatosis and a differential diagnosis are presented.
1. Case Report
A 26-year-old male overseas visitor presented with head
trauma and reduced consciousness with a Glasgow coma
scale (GCS) of 3 following a prolonged tonic-clonic seizure
which resulted in head trauma. He had a past history of
developmental delay and epilepsy. No prior imaging was
available for comparison.
A noncontrast CT brain showed a minimally depressed
right parietal bone fracture (Figure 1) but no associated
intracranial haemorrhage. A right parietooccipital poren-
cephalic cyst was located subjacent to the fracture, with
mild dilation of the right lateral ventricle and hemicerebral
atrophy (Figure 2). There was associated right calvarial
remodelling, localised cerebral cortex calcification, and sur-
rounding multifocal lipomatosis (Figures 2 and 3). The left
cerebral hemisphere was normal.
On clinical examination, there was alopecia involving
his right scalp and an overlying subcutaneous soft tissue
mass. The clinical and radiological findings were consistent
with a diagnosis of encephalocraniocutaneous lipomatosis
(ECCL), also known as Haberland syndrome. In this case,
the individual met a number of diagnostic criteria for ECCL
proposed by Moog et al. (Table 1 and Diagnosis Based on
Minor andMajor Criteria).These included twomajor criteria
of a naevus psiloliparus and intracranial lipoma and a num-
ber of minor criteria of hemispheric atrophy, porencephalic
cyst, calcification which was not basal ganglia calcification,
alopecia, and frontotemporal subcutaneous lipoma.
Diagnosis Based on Minor and Major Criteria
Definitive Case
(i) Three systems involved with major criteria in 2 or
more
(ii) Three systems involved, proven NP or possible NP,
and at least 1 minor skin criteria
(iii) Two systems involved with major criteria, one of
which is proven NP or possible NP and 1 or more
minor skin criteria
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Figure 1: Noncontrast CT bone windows. Fracture of right parietal
bone (arrow). Cortical gyriform calcifications are seen (arrowhead).
Figure 2: Noncontrast CT brain with a large right posterior parietal
porencephalic cyst with adjacent cortical calcification (arrow).There
is intracranial fat tracking along the falx and subjacent to the right
parietal bone (arrowheads).
Probable Case
(i) Two systems involved with major criteria
(ii) Two systems involved, proven or possible NP.
2. Discussion
Wepresent an unusual presentation of ECCL in a patient with
no prior imaging for comparison. The syndrome is usually
recognised and imaged at birth, but no such information was
available in this overseas visitor. The patient presented with a
skull fracture following a seizure, involving the moderately
thinned, protuberant region of calvarium that had been
remodelled by an underlying porencephalic cyst.
ECCLwas first described in 1970 byHaberland and Perou
[1, 2]. There is no specific genetic inheritance pattern and the
condition occurs spontaneously with no gender predilection.
Figure 3: The porencephalic cyst directly communicates with the
posterior horn of the right lateral ventricle (arrow) with adjacent
cerebral lipomatosis (arrowhead) and cerebral atrophy.
To date, no cases in either siblings or children of affected
individuals have been reported [2].This neurocutaneous syn-
drome is a combination of central nervous system (CNS) and
cutaneous and ocular abnormalities which can be unilateral
or bilateral [2]. The aetiology of this disorder was suggested
by Happle to be a lethal somatic mutation, able to survive due
to a mosaic state close to other genetically normal cells [3].
Moog postulated the genetic aetiology to relate to mosaicism
for a mutated autosomal gene involved in vasculogenesis and
multiple mesenchymal tumours [2]. Recently, Bennett et al.
have suggested that mosaic activating mutations in FGFR1
cause ECCL [4].
A broad spectrum of neurological impairments has been
described, varying from normal to mild developmental delay
at one end of a spectrum to profound development delay and
psychomotor retardation on the other [2]. The presence and
frequency of seizure activity also vary from no seizures in
some patients, along a spectrum ending in severe protracted
seizures or refractory epilepsy.There is no demonstrable cor-
relation between the severity of neuroimaging findings and
the severity of retardation or seizure frequency. Furthermore,
imaging has yet to provide reliable prognostic features [5].
The cerebral anomalies in ECCL are postulated by Moog
et al. to be mesenchymal abnormalities arising from neural
crest derivatives, rather than primary cerebral malformations
[5]. The commonest cerebral anomalies are lipomas which
may be intracranial and/or intraspinal, and these are thought
to result from abnormal differentiation and persistence
of the meninx primitiva. The most common location for
intracranial lipomas is at the cerebellopontine angle. Spinal
lipomatosis is very commonly observed on spinal imaging
and can extend for the entire length of the spinal cord [5].
A rare but reported association with anomalies of the
corpus callosum varying from a thin corpus callosum to
complete agenesis has been noted [5]. Asymmetric cerebral
atrophy and unilateral cortical dysplasia are frequent imaging
findings. The posterior fossa has also been reported to be
Case Reports in Neurological Medicine 3
Table 1: Diagnostic criteria (adapted fromMoog et al.).
Eye Skin CNS Other
Major Choristoma Nevus psiloliparis (NP) Intracranial or intraspinal lipoma
Jaw tumours:
(i) Osteoma
(ii) Odontoma
(iii) Nonossifying
fibroma
Multiple bone cysts
Aortic coarctation
Minor
Corneal anomalies Possible NP Abnormal intracranial vessels
Ant. chamber anomalies Patchy/streaky nonscarring alopecia(without NP)
Arachnoid cyst
Abnormalities of meninges
Ocular coloboma Frontotemporal subcutaneouslipomas
Hemispheric atrophy (complete or
partial)
Eyelid coloboma Focal aplasia/hypoplasia scalp Porencephalic cyst(s)
Calcification of globe
Small nodular skin tags on outer
eyelid (between outer canthus and
tragus)
Asymmetrically dilated ventricles
Hydrocephalus
Calcification (not basal ganglia)
affected in a small number of cases and include Dandy-
Walkermalformations and cerebellar hypoplasia and enlarge-
ment of the cerebellar cistern [5]. Intracranial calcifications
are frequently seen but do not involve the basal ganglia.
Rarely, intracranial blood vessels may be involved, including
vascular abnormalities such as leptomeningeal angiomatosis
or vascular malformations. Almost any combination of these
malformations could be observed as there is incredible
variability in this neurocutaneous disorder.
The cutaneous and ocular manifestations occur in a
more consistent pattern than the CNS findings and are
more commonly unilateral. They form an important part of
revised diagnostic criteria proposed by Moog et al. (Table 1
and Diagnosis Based on Minor and Major Criteria). ECCL
affects the dermis and hypodermis of the face and neck
and the cutaneous hallmark is considered the presence of a
nevus psiloliparus, a major skin criterion for the diagnosis
of Haberland syndrome. This is a hairless fatty nevus which
clinically looks like a bulging, soft scalp lesion with overlying
alopecia which is usually nonscarring alopecia. Initially, it
had been reported in the literature as a pathognomonic
cutaneous manifestation of ECCL until Happle and Ho¨rster
described nevus psiloliparus nevus in two nonsyndromic
cases [6]. Subcutaneous lipomas are common in the fron-
totemporal and zygomatic regions. Skin tags, nonscarring
alopecia without a lipoma and focal areas of scalp aplasia or
hypoplasia are minor cutaneous diagnostic criteria [2].
There are a number of important observed ocular anoma-
lies. Benign ocular tumours such as choristomas are the
commonest ophthalmologic manifestation [7] and a major
diagnostic criterion. Ocular and eyelid colobomas, corneal
anomalies, or abnormalities of the anterior chamber and
calcification of the globe may occur [5]. Musculoskeletal
system involvement with osteomas, odontomas, or ossifying
fibromas of the jaw ormultiple bone cysts may be present and
aortic coarctation is the principal cardiovascular finding.
The differential diagnosis of ECCL includes several other
neurocutaneous disorders with overlapping features. Proteus
syndrome can also present with cutaneous lipomas and ocu-
lar choristomas. However, it has a more progressive course
with asymmetric and disproportionate overgrowth of adipose
tissues, soft tissues, connective tissue, or bone and can present
with epidermal nevi, lipomas, or vascular malformations [7–
9]. Oculocerebrocutaneous syndrome (Delleman Oorthuys
syndrome) has some similar features but the most typical
cutaneousmanifestation is a supra-auricular hypoplastic skin
defect as opposed to the nevus psiloliparus [2, 7, 10, 11].
Oculoectodermal syndrome (Toriello-Lacassie-Droste syn-
drome) does not involve intracranial lipomas and may be
a forme fruste of ECCL [8, 12–14]. The family of epidermal
naevus syndromes also overlap with ECCL but involve an
alternate range of epidermal naevus manifestations to the
typical nevus psiloliparus [2, 7].
Patients suffering skull fractures resulting from seizure-
related injury should be considered for further evaluation
for an underlying neuroparenchymal structural abnormality,
ideally using MRI. Recognition of the characteristic neu-
roimaging and characteristic cutaneous manifestations of
ECCL is crucial to establish this syndrome from its key
differentials.
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